AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Pregawik M 750mcg/75mg Capsule

Prescription Icon
Prescription Required

Marketer

Biocube Pharma

Salt Composition

Methylcobalamin (750mcg) + Pregabalin (75mg)

Overview Pregawik M 750mcg/75mg Capsule

Gabapentinoid combination therapy, Pregawik M (750mcg/75mg capsule), is a prescribed analgesic for neuropathic pain management. It mitigates pain signals by regulating nerve cell calcium channel function. Furthermore, this medication fosters nerve fiber preservation and facilitates the repair of damaged nerve cells. Pregawik M is administered orally, with or without food, ideally before sleep. Consistent daily dosing is recommended to ensure therapeutic drug levels. Adhere strictly to your physician's prescribed dosage and duration, as this medication possesses habit-forming properties. If a dose is missed, take it immediately upon recollection. Complete the entire course of treatment, even with symptom improvement. Abrupt cessation should be avoided without prior consultation with your doctor. Commonly reported side effects include upper respiratory tract infection, increased appetite, elevated mood, tremors, visual blurring, xerostomia, vertigo, and somnolence. Refrain from operating machinery or engaging in activities requiring concentration until the drug's effects are known. Side effects generally subside over time and are usually mild. Weight gain may occur; regular exercise and a balanced diet are advised for management. Report any unusual mood or behavioral shifts, new or worsening depressive symptoms, or suicidal ideation to your doctor immediately. Comprehensive disclosure of all concurrently used medications is crucial, as drug interactions may compromise efficacy or alter the medication's effects. Notify your doctor of pregnancy, pregnancy planning, or breastfeeding.

Primary Ingredients of Pregawik M 750mcg/75mg Capsule

No text provided. Please provide the text you wish me to rephrase.

Uses of Pregawik M 750mcg/75mg Capsule

Managing neuropathic pain

Major Benefits of Pregawik M 750mcg/75mg Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for Pregawik M 750mcg/75mg Capsules. These capsules can be ingested with or without food, although consistent timing is recommended.

Common Side effects of Pregawik M 750mcg/75mg Capsule:

  • Sleepiness
  • Dizziness
  • Nasopharyngitis (inflammation of the throat and nasal passages)
  • Increased appetite
  • Blurred vision
  • Constipation
  • Muscle cramp
  • Edema (swelling)
  • Erectile dysfunction
  • Weight gain
  • Balance disorder (loss of balance)
  • Lethargy
  • Vertigo
  • Vomiting
  • Headache
  • Confusion
  • Disorientation
  • Abnormality of voluntary movements

How to use Pregawik M 750mcg/75mg Capsule:

Follow your physician's instructions precisely regarding dosage and treatment length for Pregawik M 750mcg/75mg Capsules. These capsules can be ingested with or without food, although consistent timing is recommended.

How Pregawik M 750mcg/75mg Capsule works:

Combiflam-M 750mcg/75mg capsules contain methylcobalamin and pregabalin. Methylcobalamin, a B vitamin, supports myelin sheath formation, protecting and repairing nerve cells. Pregabalin, an alpha-2-delta ligand, reduces pain by regulating nerve cell calcium channels. This combined action provides relief from neuropathic pain stemming from nerve damage.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol with Pregawik M 750mcg/75mg Capsules may lead to significant sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Pregawik M 750mcg/75mg Capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescription. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Pregawik M 750mcg/75mg Capsules while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Taking Pregawik M 750mcg/75mg Capsules might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Individuals with impaired kidney function should exercise caution when using Pregawik M 750mcg/75mg Capsules. Dosage modification may be necessary. Physician consultation is advised.

LiverLiverSAFE IF PRESCRIBED

The use of Pregawik M 750mcg/75mg Capsule in individuals with liver conditions appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary, however, a physician's consultation is recommended.

What if you forget to take Pregawik M 750mcg/75mg Capsule :

Should you forget a Pregawik M 750mcg/75mg Capsule, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Pregawik M 750mcg/75mg Capsule

LabelValue
Potential for Dependence None.
Type of Medication Nervous system (central)

FAQs on Pregawik M 750mcg/75mg Capsule

Each Pregawik M 750mcg/75mg capsule combines pregabalin and methylcobalamin. This medication is indicated for neuropathic pain management. Its mechanism involves calming overstimulated or injured nerves through central nervous system action, thus reducing pain perception. Additionally, it promotes the repair of damaged nerves.
Discontinuing Pregawik M 750mcg/75mg Capsule, even with pain relief, is inadvisable. Follow your physician's instructions for its continued use. Abrupt cessation may result in withdrawal effects including, but not limited to, anxiety, insomnia, nausea, discomfort, and diaphoresis. A gradual reduction in Pregawik M 750mcg/75mg Capsule dosage is recommended prior to complete discontinuation.
Using Pregawik M 750mcg/75mg Capsules may increase appetite, potentially leading to weight gain. Preventing this weight gain is simpler than subsequent weight loss. Maintain a nutritious, balanced diet without enlarging your meal portions. Restrict high-calorie foods like sugary drinks, fried foods, crisps, pastries, and confectionery. Between meals, choose fruits, vegetables, and low-calorie options instead of snacks. Regular physical activity aids in weight management. Consistent healthy eating and exercise may prevent weight increase.
Pregawik M 750mcg/75mg Capsules can induce drowsiness or sudden sleep onset during routine tasks. These episodes may occur without prior warning signs. Refrain from driving, operating equipment, working at heights, or engaging in hazardous activities, especially initially, until the medication's effects are known. Report any such incidents to your physician while using this medication.
Rarely, Pregawik M 750mcg/75mg Capsules may cause severe adverse reactions. These include allergic reactions (manifested by facial, oral, lip, gum, tongue, or neck swelling; breathing difficulties; skin rashes; hives; or blisters), and serious psychological effects such as suicidal ideation or limb edema (hands, feet, or legs). Discontinue use and seek immediate medical attention if any of these symptoms appear. Note any abrupt shifts in mood, behavior, thinking, or feelings, particularly if suicidal thoughts arise.
Patients may experience initial improvements with Pregawik M 750mcg/75mg Capsule within two weeks. Complete therapeutic effects, however, might not be evident for two to three months, or potentially longer in certain individuals.
Should you miss a scheduled dose of Pregawik M 750mcg/75mg Capsule, and your next dose is imminent, omit the missed dose and continue with your regular schedule. If, however, sufficient time remains before your next dose, take the missed dose immediately and then resume your usual medication regimen. Avoid doubling up on doses to compensate for a missed one; this could heighten the chance of adverse reactions. For any uncertainty regarding missed doses, seek guidance from your physician.
Increasing the prescribed dosage won't necessarily enhance treatment; it could instead heighten the risk of adverse reactions and harmful effects. If your symptoms worsen despite adhering to the recommended dosage, seek medical advice for reassessment.
Avoid consuming alcohol during your Pregawik M 750mcg/75mg Capsule treatment. Alcohol may worsen the drowsiness this medication can cause.
Regular check-ups with your physician are recommended following commencement of Pregawik M 750mcg/75mg Capsule treatment. Seek immediate medical attention if your symptoms persist or worsen despite adhering to the prescribed dosage, or if adverse effects interfere with your daily life.
Preserve your medication within its original packaging until needed. Maintain storage in a cool, dry environment. Keep the medication out of the reach and view of children. Proper disposal of any leftover medication is essential to prevent accidental ingestion by children, pets, or others.
Pregawik M 750mcg/75mg Ca...
98
MRP 120
18% off